US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tevogen Bio Holdings

1.01

+0.03163.23%

Post-market: 0.9920-0.0180-1.78%19:59 EDT

Volume:772.28K

Turnover:778.18K

Market Cap:185.73M

PE:-14.42

High:1.03

Open:0.9895

Low:0.9700

Close:0.9784

Loading ...

Overview Company News Filings

Tevogen Bio Enters Agreement to Receive up to $10 Million of Non-Dilutive Grant Funding

THOMSON REUTERS

Press Release: Tevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant Funding

Tevogen Bio CEO Congratulates Lynne Patton on Being Appointed Deputy Assistant to the President and Director of Minority Outreach

THOMSON REUTERS

Top Midday Gainers

MT Newswires Live

Tevogen Bio Shares up 28% After Co to Expand Microsoft AI Collaboration

THOMSON REUTERS

BUZZ-Tevogen Bio jumps on expanded Microsoft AI collaboration

Tevogen Bio Stock Soars on Expanded Team-Up with Microsoft

Tevogen Bio Shares Rise 60% at $2.16 Premarket After Co to Broaden AI Collaboration With Microsoft

THOMSON REUTERS

Tevogen Stock Surges on Expanded Microsoft AI Collaboration

Stocks to Watch: Richardson Electronics, Tevogen Bio Holdings

BRIEF-Tevogen Bio Broadens Relationship With Microsoft To Deepen Artificial Intelligence Collaboration

Tevogen Bio announces AI collaboration with Microsoft

Tevogen Bio Holdings: Proactively Investigating Potential Treatments for Human Papillomavirus

THOMSON REUTERS

Tevogen Bio Broadens Relationship With Microsoft to Deepen Artificial Intelligence Collaboration and Develop Predictcell Technology on Azure

THOMSON REUTERS

Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure

Tevogen files for additional patent on predictive AI

Dr. Ryan Saadi Commends Individuals Who Dedicate Time to Public Service, and Congratulates Mayor Victor Sordillo on His Induction Into the NJ League of Municipalities Hall of Fame

Tevogen announces additional responsibilities for key leaders

Tevogen Bio Prepares Organizational Readiness to Support Company’s Growth Strategy

Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company Value

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TVGN/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TVGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGN\",,,,,undefined,":{"symbol":"TVGN","market":"US","secType":"STK","nameCN":"Tevogen Bio Holdings","latestPrice":1.01,"timestamp":1746216000000,"preClose":0.9784,"halted":0,"volume":772284,"hourTrading":{"tag":"盘后","latestPrice":0.992,"preClose":1.01,"latestTime":"19:59 EDT","volume":29907,"amount":29866.2064,"timestamp":1746230399310},"delay":0,"floatShares":22757419,"shares":183893433,"eps":-0.070045,"marketStatus":"Market Closed","change":0.0316,"latestTime":"05-02 16:00:00 EDT","open":0.9895,"high":1.03,"low":0.97,"amount":778181.0061672,"amplitude":0.061325,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.070045,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.9784,"preHourTrading":{"tag":"盘前","latestPrice":0.98,"preClose":0.9784,"latestTime":"09:23 EDT","volume":8404,"amount":8138.594956800001,"timestamp":1746192222253},"postHourTrading":{"tag":"盘后","latestPrice":0.992,"preClose":1.01,"latestTime":"19:59 EDT","volume":29907,"amount":29866.2064,"timestamp":1746230399310},"volumeRatio":0.16018872693681308},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGN\",,,,,undefined,":{"symbol":"TVGN","floatShares":22757419,"roa":"-746.67%","roe":"--","lyrEps":-0.070045,"volumeRatio":0.16018872693681308,"shares":183893433,"dividePrice":0,"high":1.03,"amplitude":0.061325,"preClose":0.9784,"low":0.97,"week52Low":0.2556,"pbRate":"-12.00","week52High":3.09,"institutionHeld":0,"latestPrice":1.01,"eps":-0.070045,"divideRate":0,"volume":772284,"delay":0,"ttmEps":-0.070045,"open":0.9895,"prevYearClose":1.03,"prevWeekClose":0.9922,"prevMonthClose":1.03,"prevQuarterClose":1.08,"fiveDayClose":0.9922,"twentyDayClose":1,"sixtyDayClose":1.48},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TVGN\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2507523074","title":"Tevogen Bio Enters Agreement to Receive up to $10 Million of Non-Dilutive Grant Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2507523074","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507523074?lang=en_us&edition=fundamental","pubTime":"2025-01-29 04:49","pubTimestamp":1738097388,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250128:nTUABVJ0P0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0354030511.USD","LU2279689827.SGD","IE00BFXG0V08.USD","LU1037948897.HKD","LU1316542783.SGD","LU1670627923.USD","BK4525","IE0004445015.USD","LU0345768153.USD","MSFT","LU1366333091.USD","LU1496350171.SGD","LU1720051108.HKD","LU2413666426.HKD","SG9999014575.USD","LU2458330169.SGD","LU0965509010.AUD","LU2065169927.USD","LU0289941410.SGD","LU1917777945.USD","BK4532","LU0109391861.USD","LU0784383803.USD","LU1059921491.USD","LU0426412945.USD","TVGNW","LU0792757196.USD","LU0238689110.USD","LU0868494617.USD","LU2023251221.USD","LU0894485498.HKD","LU1334329650.SGD","IE00B5949003.HKD","LU2041044095.USD","LU0128525929.USD","LU1815336760.USD","LU2242650005.HKD","IE00BMPRXQ63.HKD","BK4576","LU2028103732.USD","LU2506952097.USD","TVGN","LU1043141123.HKD","LU2286300806.USD","LU0162691827.USD","LU0072461881.USD","LU0203202063.USD","LU1181866309.USD","LU1429558221.USD","LU0950375773.USD"],"gpt_icon":0},{"id":"2507525308","title":"Press Release: Tevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2507525308","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507525308?lang=en_us&edition=fundamental","pubTime":"2025-01-29 04:49","pubTimestamp":1738097340,"startTime":"0","endTime":"0","summary":"-- The grant funding will further Tevogen Bio's mission to develop therapies. -- Tevogen Bio may also utilize the grant funding to further expand its. -- This grant is in addition to the previously announced $36 million loan. The receipt of the grant was not dilutive to existing Tevogen Bio shareholders and comes at a time when the Company is acutely focused on furthering its mission through expansion of its artificial intelligence efforts, Tevogen.AI. Tevogen Bio remains committed to efficient operations and anticipates utilizing the grant in a judicious manner.Tevogen Bio is a clinical-stage specialty immunotherapy company harnessing one of nature's most powerful immunological weapons, CD8+ cytotoxic T lymphocytes, to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the significant unmet needs of large patient populations. Tevogen Bio Leadership believes that susta","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1323610961.USD","IE0004445015.USD","LU0082616367.USD","LU1571399168.USD","LU0316494557.USD","LU0964807845.USD","LU2362541273.HKD","LU0158827948.USD","LU1235294995.USD","LU0894486033.HKD","LU2065171311.SGD","LU2417539215.USD","LU0757359368.USD","MSFT","LU1064131342.USD","LU0203201768.USD","LU1236620750.USD","LU2244417387.USD","IE00BBT3K403.USD","LU0310800379.SGD","TVGN","LU0708994859.HKD","LU1642822529.SGD","LU2095319765.USD","LU1181866309.USD","LU2092937221.SGD","LU1712237335.SGD","LU1718418525.SGD","BK4527","BK4525","LU1003077747.HKD","LU2271345857.HKD","LU1032466523.USD","IE00BZ1G4Q59.USD","LU1564329115.USD","LU1791710582.SGD","IE00BK4W5M84.HKD","IE00BKDWB100.SGD","LU2463028550.USD","IE00BWXC8680.SGD","LU1496350502.SGD","BK4592","LU2357305700.SGD","LU0889565833.HKD","LU1244550494.USD","LU0348723411.USD","LU1435385759.SGD","LU0312595415.SGD","LU0784385170.HKD","LU0823417737.USD"],"gpt_icon":1},{"id":"2506567589","title":"Tevogen Bio CEO Congratulates Lynne Patton on Being Appointed Deputy Assistant to the President and Director of Minority Outreach","url":"https://stock-news.laohu8.com/highlight/detail?id=2506567589","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506567589?lang=en_us&edition=fundamental","pubTime":"2025-01-28 03:24","pubTimestamp":1738005873,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nTUA1LZMCS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0},{"id":"2506258320","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2506258320","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506258320?lang=en_us&edition=fundamental","pubTime":"2025-01-28 02:20","pubTimestamp":1738002017,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings  said late Friday that it broadened its relationship with Microsoft  to expand its artificial intelligence-focused collaboration while building a technology designed to help with predictive precision T-cell targeting.Shares of Tevogen advanced 30% as intraday trading volume soared to more than 48.5 million from a daily average of about 2.9 million.Aurora Mobile  said Monday that its business-oriented AI agent platform GPTBots.ai integrated the DeepSeek R1 large language model.Shares skyrocketed 166% as intraday trading volume surged to over 28.5 million from a daily average of about 15,000.Akero Therapeutics  said Monday a phase 2b study of its lead product candidate, efruxifermin, showed a \"statistically significant\" reversal of compensated cirrhosis caused by metabolic dysfunction-associated steatohepatitis, or MASH.Shares surged more than 91% as intraday trading volume catapulted to over 11.7 million from a daily average of about 723,000.Price: 1.75, Change: +0.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BMPRXN33.USD","LU0345768153.USD","BK4139","LU0476273544.USD","JG","LU0444971666.USD","LU2362540622.SGD","LU1791710582.SGD","LU0095938881.EUR","LU1934455194.USD","LU0545562505.USD","LU1633808545.USD","LU0738911758.USD","AKRO","SG9999001077.SGD","LU0757359368.USD","LU2023250504.SGD","SG9999014880.SGD","LU1066053197.SGD","LU1145028129.USD","LU1720051017.SGD","LU1791710400.SGD","LU2505996681.GBP","LU1934455277.USD","TVGN","LU0109391861.USD","LU0882574139.USD","IE00BKVL7J92.USD","LU0203201768.USD","LU0345774631.USD","LU1697837992.HKD","IE00B1XK9C88.USD","LU0823417737.USD","LU0124676726.USD","LU1804176565.USD","LU2092937148.SGD","BK4534","BK4598","LU0345770993.USD","LU1035773651.USD","LU2764262908.HKD","LU2236285917.USD","BK4577","LU2213496289.HKD","LU0127658192.USD","IE0034235295.USD","MSFT","SGXZ99366536.SGD","IE00B3S45H60.SGD","LU1983260115.SGD"],"gpt_icon":1},{"id":"2506830836","title":"Tevogen Bio Shares up 28% After Co to Expand Microsoft AI Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2506830836","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506830836?lang=en_us&edition=fundamental","pubTime":"2025-01-27 22:32","pubTimestamp":1737988346,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3438f2c5d0af3ac7098ae251e297d7d5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nFWN3ON0Q1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVGN","BK4139"],"gpt_icon":0},{"id":"2506375991","title":"BUZZ-Tevogen Bio jumps on expanded Microsoft AI collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2506375991","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506375991?lang=en_us&edition=fundamental","pubTime":"2025-01-27 19:53","pubTimestamp":1737978834,"startTime":"0","endTime":"0","summary":"BUZZ-Tevogen Bio jumps on expanded Microsoft AI collaboration** Shares of drug developer Tevogen Bio TVGN.O rise ~48% to $2 premarket** On Friday, TVGN said it is expanding its partnership with Microsoft MSFT.O to use AI to improve its immunotherapy treatments** Co's proprietary tech, PredicTcell, will be developed on Microsoft's Azure cloud platform to identify precise T-cell targets - TVGN** TVGN said it is also using MSFT's AI tools and Azure cloud platform to proactively investigate potential treatments for human papillomavirus - viral infection that can cause genital warts and certain types of cancer** Last year, TVGN announced its partnership with Microsoft, and its shares surged to ~54%** TVGN fell 90.7% in 2024  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nL3N3ON0LM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU0345770308.USD","LU1989773731.SGD","BK4532","LU2237443895.HKD","IE0034235188.USD","LU1814569148.SGD","LU1868837300.USD","LU2191332357.HKD","LU0949170772.SGD","LU2360032135.SGD","LU0545039389.USD","LU0289941410.SGD","LU1548497426.USD","LU2279689827.SGD","LU0943347566.SGD","IE00BJTD4V19.USD","IE00BFSS7M15.SGD","LU0994945656.USD","TVGN","GB00B4LPDJ14.GBP","BK4588","SG9999014898.SGD","LU0345768740.USD","LU0079474960.USD","LU0823421416.USD","LU0251132253.USD","LU1003077747.HKD","LU0689472784.USD","LU1823568750.SGD","SG9999018857.SGD","LU0320765059.SGD","LU0784383803.USD","LU2065170008.USD","LU0708994859.HKD","LU2236285917.USD","MSFT","LU0006306889.USD","LU2133065610.SGD","LU0234570918.USD","GB00BDT5M118.USD","LU1280957306.USD","LU0238689110.USD","LU0106261372.USD","LU1623119135.USD","LU1153585028.USD","LU2237957902.USD","LU0879622024.SGD","LU0444971666.USD","LU0061475181.USD"],"gpt_icon":1},{"id":"2506737763","title":"Tevogen Bio Stock Soars on Expanded Team-Up with Microsoft","url":"https://stock-news.laohu8.com/highlight/detail?id=2506737763","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506737763?lang=en_us&edition=fundamental","pubTime":"2025-01-27 19:37","pubTimestamp":1737977820,"startTime":"0","endTime":"0","summary":"Shares of Tevogen Bio surged after the company said it has broadened its relationship with Microsoft in an AI-focused collaboration to develop the biotech's proprietary technology.The stock was up 52% at $2.06 in premarket trading on Monday. Shares were trading at $7.58 this time a year ago.The Warren, N.J., company said after the market closed last week that Microsoft is using its AI and cloud capabilities to help build Tevogen's PredicTcell technology, which is designed for predictive precision T-cell targeting.Microsoft's health and life sciences domain expertise should accelerate Tevogen's target identification and pre-clinical processes, the company said.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3438f2c5d0af3ac7098ae251e297d7d5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0390134368.USD","LU1917777945.USD","LU0225283273.USD","LU2237443978.SGD","LU1914381329.SGD","LU1670628061.USD","LU0354030438.USD","LU0494093205.USD","BK4581","LU0949170426.SGD","BK4566","TVGN","LU0256863902.USD","IE000ITXATA3.USD","LU2237957902.USD","SG9999018857.SGD","IE00BDRTCR15.USD","LU0082616367.USD","LU1815336760.USD","BK4538","BK4548","LU2286300806.USD","LU0642271901.SGD","LU1670627923.USD","IE00BJTD4V19.USD","LU1429558221.USD","LU0784383803.USD","SG9999018865.SGD","LU1496350171.SGD","SG9999001424.SGD","IE00BLSP4239.USD","LU1868836591.USD","LU1064131342.USD","LU0316494557.USD","LU1181866309.USD","LU1934455277.USD","MSFT","LU0960925559.SGD","LU1852331112.SGD","LU1043141123.HKD","TISI","LU2089283258.USD","SGXZ81514606.USD","LU1196500208.SGD","LU1366192091.USD","LU1732800096.USD","LU0345768153.USD","LU0757359368.USD","IE00BQXX3D17.EUR","SG9999014914.USD"],"gpt_icon":1},{"id":"2506243743","title":"Tevogen Bio Shares Rise 60% at $2.16 Premarket After Co to Broaden AI Collaboration With Microsoft","url":"https://stock-news.laohu8.com/highlight/detail?id=2506243743","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506243743?lang=en_us&edition=fundamental","pubTime":"2025-01-27 17:50","pubTimestamp":1737971429,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3438f2c5d0af3ac7098ae251e297d7d5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250127:nL3N3ON0II:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVGN","BK4139"],"gpt_icon":0},{"id":"1132878034","title":"Tevogen Stock Surges on Expanded Microsoft AI Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=1132878034","media":"Seeking Alpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132878034?lang=en_us&edition=fundamental","pubTime":"2025-01-25 11:15","pubTimestamp":1737774900,"startTime":"0","endTime":"0","summary":"Tevogen Bio  stock jumped nearly 26% post-market after the company announced it has expanded its relationship with Microsoft  to broaden their AI-focused collaboration and build its PredicTcell technology for predictive precision T cell targeting.The Tevogen.AI initiative will integrate Microsoft's AI tools and Azure cloud platform to expand Tevogen's  ExacTcell preclinical pipeline. The initiative will also aim to develop proprietary algorithms to decode HLA-T cell interactions, according to a ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3438f2c5d0af3ac7098ae251e297d7d5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4398655-tevogen-stock-rallies-on-expanded-microsoft-ai-collaboration","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tevogen Stock Surges on Expanded Microsoft AI Collaboration","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1728464409321","symbols":["TVGN","MSFT"],"gpt_icon":1},{"id":"2506812361","title":"Stocks to Watch: Richardson Electronics, Tevogen Bio Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2506812361","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506812361?lang=en_us&edition=fundamental","pubTime":"2025-01-25 07:45","pubTimestamp":1737762300,"startTime":"0","endTime":"0","summary":"Richardson Electronics sold a majority of its healthcare arm to medical-imaging company DirectMed. The maker of engineered solutions and green-energy products said the deal will simplify its business, improve its financial model and allow it to prioritize opportunities within higher-growth markets. It also entered an exclusive 10-year global supply agreement with DirectMed under which it will supply the company with repaired Siemens CT X-ray tubes. Shares rise 12%, to $14.70, in after-hours trading.Tevogen Bio Holdings expanded its artificial-intelligence partnership with Microsoft. The immunotherapy biotech company said its AI effort, Tevogen.AI, will integrate Microsoft's advanced AI tools and the Microsoft Azure cloud platform to perform simulations that will accelerate the identification of new targets. It will additionally create new algorithms to decode the interactions between human leukocyte antigens and T cells, enhancing the company's understanding of immune responses. Shares","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823434583.USD","LU0095938881.EUR","TVGN","LU0787776722.HKD","LU2756315318.SGD","LU0048584097.USD","LU2133065610.SGD","BK4504","LU0345770993.USD","IE00B3SWFQ91.USD","BK4554","LU0069063385.USD","IE00BJTD4V19.USD","LU1435385759.SGD","LU0345768153.USD","LU0642271901.SGD","LU1366192091.USD","LU0289961442.SGD","LU1084165304.USD","LU1244550494.USD","LU0171293334.USD","RELL","LU0265550359.USD","IE00BFSS7M15.SGD","LU2237443549.SGD","IE00BYQQ9H92.USD","LU1674673428.USD","LU0823417737.USD","LU0719512351.SGD","LU0094547139.USD","LU1823568750.SGD","SG9999014559.SGD","LU1629891620.HKD","MSFT","IE00BLSP4452.SGD","LU1267930573.SGD","LU1043141123.HKD","LU0345770308.USD","LU1988902786.USD","LU1670711040.USD","LU1868837300.USD","LU0690374961.EUR","LU0965509010.AUD","LU0158827781.USD","LU2125154935.USD","LU1934455863.HKD","LU2087621335.USD","SG9999001424.SGD","LU2361044865.SGD","LU2420271590.USD"],"gpt_icon":1},{"id":"2506113598","title":"BRIEF-Tevogen Bio Broadens Relationship With Microsoft To Deepen Artificial Intelligence Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2506113598","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506113598?lang=en_us&edition=fundamental","pubTime":"2025-01-25 06:46","pubTimestamp":1737758774,"startTime":"0","endTime":"0","summary":"BRIEF-Tevogen Bio Broadens Relationship With Microsoft To Deepen Artificial Intelligence CollaborationJan 24 (Reuters) - Microsoft Corp MSFT.O:TEVOGEN BIO BROADENS RELATIONSHIP WITH MICROSOFT TO DEEPE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3438f2c5d0af3ac7098ae251e297d7d5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250124:nTUA8TJBL1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0004445015.USD","LU0690374961.EUR","LU0784384876.USD","LU2237957811.SGD","LU1642822529.SGD","LU0095938881.EUR","LU2764262908.HKD","LU2552382215.SGD","LU0823434583.USD","LU1697837992.HKD","LU1778281490.HKD","LU0187121727.USD","LU0080751232.USD","BK4548","LU2506952097.USD","LU2065171311.SGD","LU0868494617.USD","LU2592432038.USD","TVGN","LU1935042215.USD","LU0057025933.USD","LU0157215616.USD","LU1988902786.USD","LU0689626769.HKD","LU1868837136.USD","LU2362540622.SGD","TVGNW","LU0310800379.SGD","LU0792757196.USD","BK4525","LU2361045086.USD","IE00B4YYXB79.USD","MSFT","LU2237443382.USD","LU1244550577.SGD","SG9999002224.SGD","LU2111349929.HKD","LU2210149790.SGD","LU0353189763.USD","SGXZ81514606.USD","LU0426412945.USD","LU0347712357.USD","LU1267930573.SGD","LU0289739343.SGD","LU2023250330.USD","LU0889565833.HKD","LU1691799644.USD","IE00BJTD4N35.SGD","LU1868836591.USD","LU1934455863.HKD"],"gpt_icon":1},{"id":"2506811444","title":"Tevogen Bio announces AI collaboration with Microsoft","url":"https://stock-news.laohu8.com/highlight/detail?id=2506811444","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506811444?lang=en_us&edition=fundamental","pubTime":"2025-01-25 06:40","pubTimestamp":1737758413,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings Inc. (TVGN) announced that it has broadened its relationship with Microsoft (MSFT) to broaden its AI-focused collaboration and...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tevogen-bio-announces-ai-collaboration-with-microsoft?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":"3438f2c5d0af3ac7098ae251e297d7d5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tevogen-bio-announces-ai-collaboration-with-microsoft?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0323239441.USD","LU1988902786.USD","LU1244550577.SGD","LU1934455194.USD","LU1037948541.HKD","LU1366192091.USD","SG9999014880.SGD","IE00B4JS1V06.HKD","LU0960925559.SGD","IE00BMPRXR70.SGD","SG9999014575.USD","IE0034235303.USD","BK4503","LU1066051498.USD","LU0171293334.USD","LU1066051811.HKD","LU0965508806.USD","BK4504","LU1823568750.SGD","LU2236285917.USD","TVGN","LU1046421795.USD","LU0265550359.USD","GB00BDT5M118.USD","IE00BZ1G4Q59.USD","LU0784385840.USD","LU2592432038.USD","LU1548497426.USD","LU2023250330.USD","LU2361044865.SGD","LU2213496289.HKD","MSFT","BK4534","LU2106854487.HKD","LU2362541513.USD","LU0784383803.USD","SG9999014542.SGD","LU2237957811.SGD","LU0029864427.USD","LU0823417653.USD","LU2237957902.USD","LU2250418816.HKD","LU2506951875.HKD","LU2237443382.USD","LU0784384876.USD","LU0642271901.SGD","LU0310800379.SGD","LU1236620750.USD","LU1334329650.SGD","IE0004091025.USD"],"gpt_icon":0},{"id":"2506819471","title":"Tevogen Bio Holdings: Proactively Investigating Potential Treatments for Human Papillomavirus","url":"https://stock-news.laohu8.com/highlight/detail?id=2506819471","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506819471?lang=en_us&edition=fundamental","pubTime":"2025-01-25 06:34","pubTimestamp":1737758066,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250124:nTUA8TJBL1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1323610961.USD","LU0690374615.EUR","LU0994945656.USD","LU0162691827.USD","TVGN","LU1670628061.USD","MSFT","IE00B1BXHZ80.USD","IE00BN29S564.USD","LU2357305700.SGD","LU2242650005.HKD","LU0820562030.AUD","LU2552382132.HKD","IE00B3S45H60.SGD","IE00BJJMRX11.SGD","IE00BJTD4V19.USD","LU1691799644.USD","IE00B775H168.HKD","LU0149725797.USD","LU0511384066.AUD","LU1037948541.HKD","LU0965509010.AUD","LU2413666426.HKD","LU1037948897.HKD","IE00BK4W5L77.USD","LU1582986433.USD","LU0868494617.USD","LU1839511570.USD","LU1571399168.USD","LU0187121727.USD","LU0289961442.SGD","LU1069344957.HKD","LU2361045086.USD","LU0820561909.HKD","IE00BDRTCR15.USD","LU0894486033.HKD","LU1340139317.AUD","LU1066051811.HKD","SG9999014575.USD","LU0069063385.USD","LU1564329115.USD","LU1629891620.HKD","LU2756315664.SGD","LU1823568750.SGD","IE00BJJMRY28.SGD","LU0081259029.USD","LU0690374961.EUR","LU1868836914.USD","LU1429558221.USD","LU0882574139.USD"],"gpt_icon":0},{"id":"2506436819","title":"Tevogen Bio Broadens Relationship With Microsoft to Deepen Artificial Intelligence Collaboration and Develop Predictcell Technology on Azure","url":"https://stock-news.laohu8.com/highlight/detail?id=2506436819","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506436819?lang=en_us&edition=fundamental","pubTime":"2025-01-25 06:34","pubTimestamp":1737758066,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3438f2c5d0af3ac7098ae251e297d7d5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250124:nTUA8TJBL1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B3S45H60.SGD","IE00B1BXHZ80.USD","IE00BJJMRX11.SGD","TVGN","LU1340139317.AUD","IE00BN29S564.USD","IE00BK4W5L77.USD","LU1429558221.USD","LU1571399168.USD","LU1868836914.USD","LU0882574139.USD","LU0187121727.USD","LU0081259029.USD","TVGNW","LU0690374961.EUR","LU0289961442.SGD","MSFT","SG9999014575.USD","LU2242650005.HKD","LU0820561909.HKD","LU0965509010.AUD","LU0162691827.USD","IE00B775H168.HKD","LU1629891620.HKD","LU0511384066.AUD","LU1066051811.HKD","LU2756315664.SGD","LU0994945656.USD","IE00BDRTCR15.USD","LU0868494617.USD","LU2552382132.HKD","LU0690374615.EUR","IE00BJTD4V19.USD","LU2357305700.SGD","LU1037948897.HKD","LU1582986433.USD","LU1691799644.USD","LU2413666426.HKD","LU1323610961.USD","LU1839511570.USD","LU0820562030.AUD","LU1670628061.USD","IE00BJJMRY28.SGD","LU1823568750.SGD","LU1564329115.USD","LU0149725797.USD","LU0069063385.USD","LU2361045086.USD","LU0894486033.HKD","LU1069344957.HKD"],"gpt_icon":0},{"id":"2506819048","title":"Tevogen Bio Broadens Relationship with Microsoft to Deepen Artificial Intelligence Collaboration and Develop PredicTcell Technology on Azure","url":"https://stock-news.laohu8.com/highlight/detail?id=2506819048","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506819048?lang=en_us&edition=fundamental","pubTime":"2025-01-25 06:34","pubTimestamp":1737758040,"startTime":"0","endTime":"0","summary":"This expansion is in addition to the previously announced Microsoft for Startups program.PredicTcell, Tevogen Bio’s proprietary technology, is designed for predictive, precision T cell target identification.Tevogen Bio is also proactively investigating potential treatments for Human Papillomavirus .Tevogen.AI, Tevogen Bio’s artificial intelligence effort, will integrate Microsoft’s advanced AI tools and the Microsoft Azure cloud platform into two key objectives:. Rapidly Expanding the ExacTcell Technology Pre-Clinical PipelineBuilding on the successful trial results of TVGN 489, Tevogen Bio aims to utilize machine learning to perform critical simulations that will accelerate the identification of new targets. By leveraging Microsoft’s AI, the company can analyze large datasets across the genome with greater speed and accuracy.By leveraging the Microsoft Azure cloud platform and a suite of advanced AI tools, Tevogen Bio is also proactively investigating potential treatments for Human Pa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3438f2c5d0af3ac7098ae251e297d7d5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tevogen-bio-broadens-relationship-microsoft-223400494.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0289739343.SGD","IE00BBT3K403.USD","LU1188199696.SGD","LU1037948897.HKD","LU2458330169.SGD","IE0004086264.USD","LU2095319765.USD","LU2347655156.SGD","LU1235295455.SGD","LU2087621335.USD","IE00B7KXQ091.USD","LU1116320737.USD","BK4503","LU1732800096.USD","BK4554","IE00B1BXHZ80.USD","LU1551013342.USD","LU0965509010.AUD","LU1815333072.USD","IE00BKDWB100.SGD","LU0683600562.USD","TVGN","LU0069063385.USD","LU2237438978.USD","LU0661504455.SGD","LU0823421416.USD","LU0689472784.USD","IE00BWXC8680.SGD","LU0267386448.USD","TVGNW","LU1670711123.USD","LU2213496289.HKD","SG9999014914.USD","LU2756315318.SGD","LU2506951958.HKD","LU0820561909.HKD","LU1059921491.USD","MSFT","BK4534","LU0175139822.USD","LU1506573853.SGD","BK4516","LU0949170426.SGD","LU0553294199.USD","IE00BJLML261.HKD","LU0719512351.SGD","LU2237957902.USD","LU2326559502.SGD","LU1116320901.HKD","SG9999001424.SGD","LU0265550946.USD","IE0004445239.USD"],"gpt_icon":1},{"id":"2492217318","title":"Tevogen files for additional patent on predictive AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2492217318","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492217318?lang=en_us&edition=fundamental","pubTime":"2024-12-19 21:50","pubTimestamp":1734616228,"startTime":"0","endTime":"0","summary":"Tevogen (TVGN) Bio filed for an additional patent, “Systems And Methods For Predicting Immunologically Active Peptides With Machine Learning Models...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tevogen-files-for-additional-patent-on-predictive-ai?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tevogen-files-for-additional-patent-on-predictive-ai?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TVGN"],"gpt_icon":0},{"id":"2489469783","title":"Dr. Ryan Saadi Commends Individuals Who Dedicate Time to Public Service, and Congratulates Mayor Victor Sordillo on His Induction Into the NJ League of Municipalities Hall of Fame","url":"https://stock-news.laohu8.com/highlight/detail?id=2489469783","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489469783?lang=en_us&edition=fundamental","pubTime":"2024-12-06 00:03","pubTimestamp":1733414580,"startTime":"0","endTime":"0","summary":"WARREN, N.J., Dec. 05, 2024  -- Dr. Ryan Saadi, CEO of Tevogen Bio  , a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, congratulates Board Member, Victor Sordillo PE, CSP, MBA, as he was inducted into The New Jersey League of Municipalities Hall of Fame this month.Mayor Sordillo was inducted into the Hall of Fame for his dedicated tenure of 24 years of continuous service as a Warren Township Committee Member. As an elected official, Mayor Sordillo served the community by leading the municipal government, providing oversight to the township’s operations, and implementing policies for the public good, essentially working for the benefit of the citizens he represents.Tevogen is a clinical-stage specialty immunotherapy company harnessing one of nature’s most powerful immunological weapons, CD8+ cytotoxic T lymphocytes, to develop off-the-shelf, genetically unmodified precision T ce","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Hca4JbhEpE2GIG980_m0Og--~B/aD0xMzE2O3c9ODc3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b4ce4244d7a99470b7b5aca6271af6d7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Hca4JbhEpE2GIG980_m0Og--~B/aD0xMzE2O3c9ODc3O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/b4ce4244d7a99470b7b5aca6271af6d7"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/dr-ryan-saadi-commends-individuals-160300813.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2486070180","title":"Tevogen announces additional responsibilities for key leaders","url":"https://stock-news.laohu8.com/highlight/detail?id=2486070180","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486070180?lang=en_us&edition=fundamental","pubTime":"2024-11-26 21:15","pubTimestamp":1732626920,"startTime":"0","endTime":"0","summary":"Tevogen (TVGN) Bio announced addition responsibilities for key leaders to further expand company capabilities. As part of this leadership evolution...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tevogen-announces-additional-responsibilities-for-key-leaders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tevogen-announces-additional-responsibilities-for-key-leaders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TVGN"],"gpt_icon":0},{"id":"2486407771","title":"Tevogen Bio Prepares Organizational Readiness to Support Company’s Growth Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2486407771","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486407771?lang=en_us&edition=fundamental","pubTime":"2024-11-26 21:05","pubTimestamp":1732626300,"startTime":"0","endTime":"0","summary":"WARREN, N.J., Nov. 26, 2024  -- Tevogen Bio  , a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, today announced addition responsibilities for key leaders to further expand company capabilities.Tapan V Shah, Head of Investor Relations and Corporate Development, will take on added responsibility for US Government Affairs and Policy.William Keane, Vice President of Strategic Initiatives, will assume additional responsibilities for New Business Development.Wojtek Stobinski, Corporate Identity Lead, will oversee the business integration of any potential future acquisitions.Commitment to C.O.R.E. Values: Curiosity, Optimism, Respect, and Equality. Tevogen Bio’s culture, known as C.O.R.E., underpins the company’s mission and fosters a collaborative environment built on Curiosity, Optimism, Respect, and Equality. These values are more than guiding principles—they are foundational to ho","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/BJRd_xndXodq.4BrmsL4bg--~B/aD02Mjg7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/927ad684614f9ce891b7a2e4313e2d86","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/BJRd_xndXodq.4BrmsL4bg--~B/aD02Mjg7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/927ad684614f9ce891b7a2e4313e2d86"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/tevogen-bio-prepares-organizational-readiness-130500359.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2485428845","title":"Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2485428845","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485428845?lang=en_us&edition=fundamental","pubTime":"2024-11-22 04:59","pubTimestamp":1732222783,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nTUA1YPKL2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":78,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TVGN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-02-15","symbol":"TVGN","reason":null,"defaultRemindTime":1708007400000,"announcedDate":"2024-02-14","type":"delisting","dateTimestamp":1707973200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TVGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TVGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1741752000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TVGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TVGN","date":"2025-05-02","current":-13.10675,"percent":0.681004,"low":-87.683882,"twenty":-32.74034,"median":-21.917772,"eighty":-7.830197,"high":-2.106753,"avg":-22.867361,"sd":16.134682,"marketCap":179921334},"quantilePoints":[{"date":"2024-03-01","current":-58.029616,"twenty":-57.969868,"median":-57.58151,"eighty":-55.109463,"marketCap":1279054027},{"date":"2024-03-08","current":-55.116932,"twenty":-57.969868,"median":-57.3948,"eighty":-55.049716,"marketCap":1214854404},{"date":"2024-03-15","current":-48.544723,"twenty":-57.715942,"median":-55.116932,"eighty":-49.664986,"marketCap":1069993717},{"date":"2024-03-22","current":-31.890149,"twenty":-57.596447,"median":-52.465643,"eighty":-44.108482,"marketCap":702903564},{"date":"2024-03-28","current":-25.919148,"twenty":-57.357457,"median":-49.38492,"eighty":-32.983824,"marketCap":571294337},{"date":"2024-04-05","current":-25.392625,"twenty":-55.998205,"median":-48.543977,"eighty":-28.607629,"marketCap":559689021},{"date":"2024-04-12","current":-18.446995,"twenty":-55.146806,"median":-35.064227,"eighty":-23.267262,"marketCap":406597612},{"date":"2024-04-19","current":-15.833048,"twenty":-54.915285,"median":-32.71989,"eighty":-19.118705,"marketCap":348982566},{"date":"2024-04-26","current":-6.348156,"twenty":-53.503754,"median":-29.329228,"eighty":-17.595595,"marketCap":139922255},{"date":"2024-05-03","current":-7.365355,"twenty":-52.428301,"median":-25.919148,"eighty":-15.026459,"marketCap":162342739},{"date":"2024-05-10","current":-2.698495,"twenty":-50.822591,"median":-23.061357,"eighty":-9.708944,"marketCap":163198734},{"date":"2024-05-17","current":-2.422494,"twenty":-49.291565,"median":-20.164731,"eighty":-7.316959,"marketCap":146506832},{"date":"2024-05-24","current":-2.231961,"twenty":-48.694091,"median":-18.372311,"eighty":-2.71254,"marketCap":134983822},{"date":"2024-05-31","current":-2.106753,"twenty":-48.544425,"median":-17.961548,"eighty":-2.656034,"marketCap":127411559},{"date":"2024-06-07","current":-8.033143,"twenty":-47.558444,"median":-17.550785,"eighty":-2.656034,"marketCap":148265257},{"date":"2024-06-14","current":-7.903098,"twenty":-44.108482,"median":-15.833048,"eighty":-2.68298,"marketCap":145865070},{"date":"2024-06-21","current":-6.795171,"twenty":-36.221832,"median":-12.47226,"eighty":-2.696046,"marketCap":125416385},{"date":"2024-06-28","current":-6.570165,"twenty":-35.295748,"median":-12.322891,"eighty":-2.697026,"marketCap":121263525},{"date":"2024-07-05","current":-6.173255,"twenty":-33.757254,"median":-8.033143,"eighty":-2.703177,"marketCap":113937879},{"date":"2024-07-12","current":-6.299258,"twenty":-33.071802,"median":-7.830197,"eighty":-2.721904,"marketCap":116263481},{"date":"2024-07-15","current":-6.435162,"twenty":-32.983824,"median":-7.830197,"eighty":-2.721904,"marketCap":118771808},{"date":"2024-08-02","current":-5.57114,"twenty":-32.895846,"median":-7.830197,"eighty":-2.721904,"marketCap":102824824},{"date":"2024-08-09","current":-5.526139,"twenty":-32.222045,"median":-7.468419,"eighty":-3.563104,"marketCap":101994252},{"date":"2024-08-16","current":-20.612899,"twenty":-30.545833,"median":-7.468046,"eighty":-4.127144,"marketCap":122353801},{"date":"2024-08-23","current":-17.275162,"twenty":-29.265149,"median":-7.830197,"eighty":-4.681198,"marketCap":102541700},{"date":"2024-08-30","current":-14.308285,"twenty":-28.407028,"median":-7.866648,"eighty":-5.281333,"marketCap":84930944},{"date":"2024-09-06","current":-12.936966,"twenty":-27.171154,"median":-9.617885,"eighty":-5.454137,"marketCap":76791088},{"date":"2024-09-13","current":-14.230663,"twenty":-25.708539,"median":-12.097501,"eighty":-5.499138,"marketCap":84470197},{"date":"2024-09-20","current":-12.649478,"twenty":-24.871927,"median":-12.454498,"eighty":-5.544139,"marketCap":75084620},{"date":"2024-09-27","current":-11.784139,"twenty":-23.267262,"median":-12.36199,"eighty":-5.658262,"marketCap":69948149},{"date":"2024-10-04","current":-8.756889,"twenty":-21.942215,"median":-12.240382,"eighty":-5.887588,"marketCap":51979034},{"date":"2024-10-11","current":-9.208245,"twenty":-21.329829,"median":-12.040003,"eighty":-6.069393,"marketCap":54658190},{"date":"2024-10-18","current":-39.673363,"twenty":-24.871927,"median":-12.127687,"eighty":-6.141394,"marketCap":235492672},{"date":"2024-10-25","current":-73.596963,"twenty":-29.393307,"median":-12.327491,"eighty":-6.173255,"marketCap":436855971},{"date":"2024-10-31","current":-70.722082,"twenty":-31.779361,"median":-12.436737,"eighty":-6.180635,"marketCap":419791285},{"date":"2024-11-08","current":-32.773648,"twenty":-33.757254,"median":-12.633666,"eighty":-6.224556,"marketCap":194537424},{"date":"2024-11-15","current":-42.548244,"twenty":-38.983392,"median":-12.936966,"eighty":-6.285578,"marketCap":252557358},{"date":"2024-11-22","current":-36.270609,"twenty":-39.155884,"median":-13.187081,"eighty":-6.299438,"marketCap":287084045},{"date":"2024-11-29","current":-28.972255,"twenty":-38.235922,"median":-13.602501,"eighty":-6.300158,"marketCap":229317133},{"date":"2024-12-06","current":-23.222036,"twenty":-37.373458,"median":-13.816575,"eighty":-6.348156,"marketCap":183803809},{"date":"2024-12-13","current":-22.337387,"twenty":-36.270609,"median":-14.269474,"eighty":-6.435162,"marketCap":176801759},{"date":"2024-12-20","current":-21.33331,"twenty":-36.221832,"median":-15.004006,"eighty":-6.508963,"marketCap":168854432},{"date":"2024-12-27","current":-23.222036,"twenty":-35.303209,"median":-15.833048,"eighty":-6.557925,"marketCap":183803809},{"date":"2025-01-03","current":-23.443198,"twenty":-34.373394,"median":-17.065337,"eighty":-6.580965,"marketCap":185554321},{"date":"2025-01-10","current":-28.52993,"twenty":-33.790638,"median":-17.550785,"eighty":-6.670967,"marketCap":225816108},{"date":"2025-01-17","current":-26.760632,"twenty":-33.439732,"median":-17.684618,"eighty":-6.873653,"marketCap":211812008},{"date":"2025-01-24","current":-30.52039,"twenty":-33.171426,"median":-18.032197,"eighty":-7.005548,"marketCap":241570720},{"date":"2025-01-31","current":-29.635741,"twenty":-33.528197,"median":-18.446995,"eighty":-7.075423,"marketCap":234568670},{"date":"2025-02-07","current":-31.405039,"twenty":-33.171426,"median":-19.295444,"eighty":-7.138439,"marketCap":248572770},{"date":"2025-02-14","current":-34.501311,"twenty":-33.892862,"median":-20.164731,"eighty":-7.192457,"marketCap":273079945},{"date":"2025-02-21","current":-34.280148,"twenty":-34.280148,"median":-20.612899,"eighty":-7.244366,"marketCap":271329432},{"date":"2025-02-28","current":-27.645281,"twenty":-34.280148,"median":-21.570546,"eighty":-7.365355,"marketCap":218814058},{"date":"2025-03-07","current":-24.327847,"twenty":-34.058986,"median":-22.031836,"eighty":-7.370735,"marketCap":192556371},{"date":"2025-03-14","current":-24.54901,"twenty":-33.906622,"median":-22.226806,"eighty":-7.443187,"marketCap":194306884},{"date":"2025-03-21","current":-25.875983,"twenty":-33.837824,"median":-22.558549,"eighty":-7.452187,"marketCap":204809958},{"date":"2025-03-28","current":-26.53947,"twenty":-33.616662,"median":-23.000874,"eighty":-7.454567,"marketCap":210061496},{"date":"2025-04-04","current":-13.396106,"twenty":-33.174337,"median":-23.222036,"eighty":-7.467672,"marketCap":183893433},{"date":"2025-04-11","current":-13.396106,"twenty":-33.15978,"median":-22.669131,"eighty":-7.468419,"marketCap":183893433},{"date":"2025-04-17","current":-13.664028,"twenty":-32.994496,"median":-22.447968,"eighty":-7.468419,"marketCap":187571301},{"date":"2025-04-25","current":-13.530067,"twenty":-32.809553,"median":-22.063146,"eighty":-7.757841,"marketCap":185732367},{"date":"2025-05-02","current":-13.10675,"twenty":-32.74034,"median":-21.917772,"eighty":-7.830197,"marketCap":179921334}],"updateTime":1746323303081}}}